News

Novelix Pharmaceuticals announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 1 July 2026.

Novelix Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 4 June 2026.

Net profit of Novelix Pharmaceuticals rose 405.56% to Rs 0.91 crore in the quarter ended March 2026 as against Rs 0.18 crore during the previous quarter ended March 2025. Sales rose 20.76% to Rs 25.19 crore in the quarter ended March 2026 as against Rs 20.86 crore during the previous quarter ended March 2025.For the full year,net profit rose 3100.00% to Rs 2.56 crore in the year ended March 2026 as against Rs 0.08 crore during the previous year ended March 2025. Sales rose 330.70% to Rs 132.31 crore in the year ended March 2026 as against Rs 30.72 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales25.1920.86 21 132.3130.72 331 OPM %5.081.10 -2.630.46 - PBDT1.280.23 457 3.510.16 2094 PBT1.230.21 486 3.410.12 2742 NP0.910.18 406 2.560.08 3100 Powered by Capital Market - Live News

Novelix Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 29 May 2026.

Net profit of Novelix Pharmaceuticals rose 566.67% to Rs 1.00 crore in the quarter ended December 2025 as against Rs 0.15 crore during the previous quarter ended December 2024. Sales rose 813.21% to Rs 48.40 crore in the quarter ended December 2025 as against Rs 5.30 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales48.405.30 813 OPM %2.712.45 - PBDT1.310.13 908 PBT1.280.13 885 NP1.000.15 567 Powered by Capital Market - Live News